Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10751199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction

  2005cited by this paper
• Review of risk factors for cardiovascular diseases.

  1999cited by this paper
• Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.

  1999cited by this paper
• Activation of Plasminogen Activator Inhibitor-1 Synthesis by Phorbol Esters in Human Promyelocyte HL-60

  1999cited by this paper
• Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).

  1998cited by this paper
• Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.

  1998cited by this paper
• Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells.

  1997cited by this paper
• (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.

  1996cited by this paper
• Synergistic augmentation of expression of plasminogen activator inhibitor type‐1 induced by insulin, very‐low-density lipoproteins, and fatty acids

  1996cited by this paper
• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells.

  1996cited by this paper
• Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.

  1995cited by this paper
• Differential responses of protein kinase C substrates (MARCKS, neuromodulin, and neurogranin) phosphorylation to calmodulin and S100.

  1995cited by this paper
• Glycation accelerates the oxidation of low density lipoprotein by copper ions.

  1995cited by this paper
• Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages.

  1994cited by this paper
• Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease.

  1994cited by this paper
• Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation.

  1994cited by this paper
• Lp(a) lipoprotein: an overview.

  1994cited by this paper
• Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.

  1994cited by this paper
• Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a).

  1994cited by this paper
• Phosphatidylinositol turnover during stimulation of plasminogen activator inhibitor-1 secretion induced by oxidized low density lipoproteins in human endothelial cells.

  1993cited by this paper
• Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.

  1993cited by this paper
• Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C.

  1993cited by this paper
• Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon.

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages.

  1992cited by this paper
• Oxidative modification of lipoprotein(a) and the effect of beta-carotene.

  1992cited by this paper
• Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells.

  1991cited by this paper
• Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin

  1990cited by this paper
• Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.

  1989cited by this paper
• The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

  1988cited by this paper
• Characterization of the chicken oocyte receptor for low and very low density lipoproteins.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

  1986cited by this paper
• Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

  1985cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

  1984cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper

• Diacylglycerol kinases: Molecular mechanism of cellular and physiological functions.

  2026cites this paper
• Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis

  2025cites this paper
• Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues

  2024cites this paper
• LDL Affects the Immunomodulatory Response of Endothelial Cells by Modulation of the Promyelocytic Leukemia Protein (PML) Expression via PKC

  2023cites this paper
• The Toxicity and Effecting Mechanism of Huan Nao Yi Cong Decoction: A Lipidomics Approach

  2022cites this paper
• LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium

  2022cites this paper
• A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.

  2020cites this paper
• Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule

  2020cites this paper
• Endothelial–mesenchymal transition in atherosclerosis

  2018cites this paper
• PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.

  2017cites this paper
• The role of iron in the pathogenesis of atherosclerosis.

  2017cites this paper
• Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study

  2017cites this paper
• Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

  2015cites this paper
• Endoplasmic reticulum stress in diabetic mouse or glycated LDL-treated endothelial cells: protective effect of Saskatoon berry powder and cyanidin glycans.

  2015cites this paper
• Podocyte dysfunction in atypical haemolytic uraemic syndrome

  2015cites this paper
• Genetics of atypical haemolytic uraemic syndrome

  2015influential citation
• AKAP150 mobilizes cPKC-dependent cardiac glucotoxicity.

  2014cites this paper
• Involvement of fibrinolytic regulators in adhesion of monocytes to vascular endothelial cells induced by glycated LDL and to aorta from diabetic mice

  2014cites this paper
• Exposure of cardiac microvascular endothelial cells to harmful stimuli : a study of the cellular responses and mechanisms

  2014cites this paper
• NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect

  2013cites this paper
• Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

  2013cites this paper
• Oxidized Lipoprotein(a) Increases Endothelial Cell Monolayer Permeability via ROS Generation

  2013cites this paper
• Impact of Cyanidin-3-Glucoside on Glycated LDL-Induced NADPH Oxidase Activation, Mitochondrial Dysfunction and Cell Viability in Cultured Vascular Endothelial Cells

  2012cites this paper
• Lipoprotein(a): Cellular Effects and Molecular Mechanisms

  2012cites this paper
• Influence of delphinidin-3-glucoside on oxidized low-density lipoprotein-induced oxidative stress and apoptosis in cultured endothelial cells.

  2012cites this paper
• Involvement of NADPH oxidase in up-regulation of plasminogen activator inhibitor-1 and heat shock factor-1 in mouse embryo fibroblasts induced by oxidized LDL and in apolipoprotein E-deficient mice

  2011cites this paper
• Impact of diabetes-associated lipoproteins on oxygen consumption and mitochondrial enzymes in porcine aortic endothelial cells.

  2010cites this paper
• Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

  2010cites this paper
• Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

  2009cites this paper
• Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.

  2008cites this paper
• Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.

  2007cites this paper
• Effects of oxidized and glycated low-density lipoproteins on transcription and secretion of plasminogen activator inhibitor-1 in vascular endothelial cells.

  2006cites this paper
• Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis

  2006cites this paper
• Oxidized LDL , a critical factor in atherogenesis B

  2005cites this paper
• De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.

  2005cites this paper
• Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.

  2005cites this paper
• Oxidized LDL, a critical factor in atherogenesis.

  2005cites this paper
• Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells

  2004cites this paper
• Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

  2004cites this paper
• LOX-1 Mediates Oxidized Low-Density Lipoprotein-Induced Expression of Matrix Metalloproteinases in Human Coronary Artery Endothelial Cells

  2003cites this paper
• Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

  2002cites this paper
• The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta.

  2002cites this paper
• Statin-Induced Expression of Decay-Accelerating Factor Protects Vascular Endothelium Against Complement-Mediated Injury

  2002cites this paper
• Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1.

  2001cites this paper
• Adenovirus-Mediated Overexpression of Dominant-Negative Mutant of c-Jun Prevents Intercellular Adhesion Molecule-1 Induction by LDL: A Critical Role for Activator Protein-1 in Endothelial Activation

  2001cites this paper
• Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon.

  2001cites this paper